Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
TTEC Holdings
TTEC
$77.4M
| $19.4M | 0.02% |
404,700
+16,800
| +4% | +$787K |
|
977
BlackBerry
BB
$5.27B
| $19.4M | 0.02% |
3,690,344
-2,408,743
| -39% | -$16.9M |
|
978
Kimberly-Clark
KMB
$36.8B
| $19.3M | 0.02% |
136,200
+110,100
| +422% | +$15.1M |
|
|
TBNK
979
DELISTED
Territorial Bancorp Inc.
TBNK
| $19.3M | 0.02% |
676,479
+18,779
| +3% | +$536K |
|
980
Blackstone Mortgage Trust
BXMT
$2.41B
| $19.3M | 0.02% |
537,680
-101,600
| -16% | -$3.61M |
|
|
CUTR
981
DELISTED
Cutera, Inc.
CUTR
| $19.3M | 0.02% |
659,000
+10,400
| +2% | +$286K |
|
982
Westwood Holdings Group
WHG
$183M
| $19.2M | 0.02% |
693,622
-3,600
| -0.5% | -$109K |
|
|
VEDL
983
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $19.2M | 0.02% |
2,208,100
+227,800
| +12% | +$1.96M |
|
984
Mesa Laboratories
MLAB
$631M
| $19.1M | 0.02% |
80,500
+33,700
| +72% | +$7.79M |
|
985
Rayonier Advanced Materials
RYAM
$561M
| $19.1M | 0.02% |
4,418,557
+554,157
| +14% | +$2.37M |
|
986
Quanex
NX
$1B
| $19M | 0.02% |
1,052,800
+184,600
| +21% | +$3.32M |
|
987
Zions Bancorporation
ZION
$10.5B
| $19M | 0.02% |
426,495
-719,084
| -63% | -$31.1M |
|
988
Graphic Packaging
GPK
$3.46B
| $18.9M | 0.02% |
1,278,818
+446,064
| +54% | +$6.26M |
|
|
SAFE
989
Safehold
SAFE
$1.09B
| $18.8M | 0.02% |
295,525
+243,117
| +464% | +$15.3M |
|
990
CRA International
CRAI
$1.07B
| $18.7M | 0.02% |
446,575
-19,156
| -4% | -$779K |
|
|
GRA
991
DELISTED
W.R. Grace & Co.
GRA
| $18.7M | 0.02% |
280,600
-274,400
| -49% | -$19.2M |
|
|
SVC
992
Service Properties Trust
SVC
$1.06B
| $18.7M | 0.02% |
145,080
-83,920
| -37% | -$10.4M |
|
993
Kemper
KMPR
$1.56B
| $18.7M | 0.02% |
239,746
+31,900
| +15% | +$2.55M |
|
994
Sibanye-Stillwater
SBSW
$7.42B
| $18.6M | 0.02% |
3,452,930
+284,800
| +9% | +$1.45M |
|
995
First Interstate BancSystem
FIBK
$3.7B
| $18.6M | 0.02% |
463,083
-37,700
| -8% | -$1.48M |
|
996
Hudbay
HBM
$11.8B
| $18.6M | 0.02% |
5,155,809
+972,600
| +23% | +$3.96M |
|
997
Accenture
ACN
$109B
| $18.6M | 0.02% |
+96,600
| New | +$18.7M |
|
|
DOOR
998
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $18.6M | 0.02% |
320,100
+50,800
| +19% | +$2.7M |
|
999
Bankunited
BKU
$3.38B
| $18.6M | 0.02% |
551,800
+77,900
| +16% | +$2.54M |
|
1000
Employers Holdings
EIG
$864M
| $18.5M | 0.02% |
425,400
+9,100
| +2% | +$395K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.